Singapore’s Q & M Dental Group Limited announced the release of the “Treatment Plan” on its Artificial Intelligence (AI)-module

image credits: Biospectrum Asia

Singapore’s Q & M Dental Group Limited announced the release of the “Treatment Plan” on its Artificial Intelligence (AI)-module developed by its 4 percent-owned subsidiary, EM2AI, in collaboration with AI Singapore.

The "Treatment Plan" AI-Module leverages state-of-the-art technology including Large Language Models (LLM) to optimise treatment recommendations. It combines conventional clinical decision support systems, with the advanced processing capabilities of LLM to understand and interpret all data and input effectively.

The tangible benefits for patients include early detection of oral health issues with suggested treatment options based on conditions detected and analysed by AI;an iterative platform that learns continuously. It will also allow patients to be informed of all available treatment options for their individual condition, that is AI-based, resulting in more objective decision-making. By integrating the latest advancements in LLM, this innovative approach enhances the accuracy of treatment options, instilling confidence in dental professionals by providing reliable insights tailored specifically for each patient.

Starting with the initial consultation and followed by x-ray imaging, the AI swiftly analyses the x-rays for pathologies, auto-generates treatment options and the journey ends with a dental health report that patients can bring back home. This complete and streamlined workflow not only enhances patient satisfaction but also empowers Q & M to deliver superior care to patients with confidence.

Dr Ng Chin Siau, Group Chief Executive Officer of Q & M, said, “This latest release of the AI-Treatment Plan module signifies a significant advancement in our dental clinics’ digital capabilities and enables the Group to offer this enhanced service to patients within its network.”